Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agentsDario Ferrero, Mario Boccadoro, Benedetto Bruno et al.|Annals of Hematology|2014Cited by 31
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allograftingAlessandro Busca, Benedetto Bruno, Roberto Passera et al.|Bone Marrow Transplantation|2018Cited by 17
The Outcome of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP (R-CHOP) Is Not Predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) Performed at Intermediate In-Course Evaluation, but Only by PET Assessed at the End of Therapy.Umberto Vitolo, G Bisi, Annalisa Chiappella et al.|Blood|2010Cited by 4
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic LeukemiaLuisa Giaccone, Filippo Marmont, Ernesta Audisio et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 3